Your browser doesn't support javascript.
loading
Investigation of Rare Non-Coding Variants in Familial Multiple Myeloma.
Niazi, Yasmeen; Paramasivam, Nagarajan; Blocka, Joanna; Kumar, Abhishek; Huhn, Stefanie; Schlesner, Matthias; Weinhold, Niels; Sijmons, Rolf; De Jong, Mirjam; Durie, Brian; Goldschmidt, Hartmut; Hemminki, Kari; Försti, Asta.
Afiliação
  • Niazi Y; Hopp Children's Cancer Center (KiTZ), 69120 Heidelberg, Germany.
  • Paramasivam N; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), 69120 Heidelberg, Germany.
  • Blocka J; Computational Oncology, Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT), 69120 Heidelberg, Germany.
  • Kumar A; Department of Internal Medicine V, University of Heidelberg, 69120 Heidelberg, Germany.
  • Huhn S; Department of Medical Oncology, Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
  • Schlesner M; Harvard Medical School, Boston, MA 02115, USA.
  • Weinhold N; Institute of Bioinformatics, International Technology Park, Bangalore 560066, India.
  • Sijmons R; Manipal Academy of Higher Education (MAHE), Manipal 576104, India.
  • De Jong M; Department of Internal Medicine V, University of Heidelberg, 69120 Heidelberg, Germany.
  • Durie B; National Center for Tumor Diseases Heidelberg (NCT), 69120 Heidelberg, Germany.
  • Goldschmidt H; Bioinformatics and Omics Data Analytics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
  • Hemminki K; Department of Internal Medicine V, University of Heidelberg, 69120 Heidelberg, Germany.
  • Försti A; University Medical Center Groningen, University of Groningen, 9712 Groningen, The Netherlands.
Cells ; 12(1)2022 12 26.
Article em En | MEDLINE | ID: mdl-36611892
ABSTRACT
Multiple myeloma (MM) is a plasma cell malignancy whereby a single clone of plasma cells over-propagates in the bone marrow, resulting in the increased production of monoclonal immunoglobulin. While the complex genetic architecture of MM is well characterized, much less is known about germline variants predisposing to MM. Genome-wide sequencing approaches in MM families have started to identify rare high-penetrance coding risk alleles. In addition, genome-wide association studies have discovered several common low-penetrance risk alleles, which are mainly located in the non-coding genome. Here, we further explored the genetic basis in familial MM within the non-coding genome in whole-genome sequencing data. We prioritized and characterized 150 upstream, 5' untranslated region (UTR) and 3' UTR variants from 14 MM families, including 20 top-scoring variants. These variants confirmed previously implicated biological pathways in MM development. Most importantly, protein network and pathway enrichment analyses also identified 10 genes involved in mitogen-activated protein kinase (MAPK) signaling pathways, which have previously been established as important MM pathways.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Estudo de Associação Genômica Ampla / Mieloma Múltiplo Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Estudo de Associação Genômica Ampla / Mieloma Múltiplo Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article